Trials / Recruiting
RecruitingNCT06806787
Copeptin and Thirst: Possible Predictive Markers of Effectiveness of Bariatric Surgery?
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, non-pharmacological, spontaneous, single-center, interventional study.
Detailed description
COPTBAR is a prospective, nonpharmacological spontaneous single-center interventional study. Laboratory tests and imaging study (complete abdomen ultrasonography) for monitoring patients will be conducted in accordance with normal clinical practice. In addition, periodic copeptin assay will be performed. Each patient, within the study protocol, will be evaluated for 12 months; thereafter, each patient will fall under the follow-up visits provided by normal clinical practice and by Corporate Diagnostic Therapeutic Pathway (PDTA).
Conditions
Timeline
- Start date
- 2023-09-13
- Primary completion
- 2026-03-13
- Completion
- 2026-03-14
- First posted
- 2025-02-04
- Last updated
- 2025-02-04
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06806787. Inclusion in this directory is not an endorsement.